TY  - GEN
AU  - Klein,David J
AU  - Battelino,Tadej
AU  - Chatterjee,D J
AU  - Jacobsen,Lisbeth V
AU  - Hale,Paula M
AU  - Arslanian,Silva
TI  - Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial
SN  - 1557-8593
PY  - 2015///0715
KW  - Adolescent
KW  - Age of Onset
KW  - Belgium
KW  - epidemiology
KW  - Blood Glucose
KW  - drug effects
KW  - Body Weight
KW  - Child
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Glucagon-Like Peptide 1
KW  - administration & dosage
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Liraglutide
KW  - Pediatric Obesity
KW  - complications
KW  - Prevalence
KW  - Slovenia
KW  - Treatment Outcome
KW  - United Kingdom
KW  - United States
KW  - Weight Loss
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1089/dia.2013.0366
ER  -